Literature DB >> 11032694

Assessment of coronary calcification by electron-beam computed tomography in symptomatic patients with normal, abnormal or equivocal exercise stress test.

A Schmermund1, D Baumgart, S Sack, S Möhlenkamp, D Grönemeyer, R Seibel, R Erbel.   

Abstract

AIMS: Exercise stress testing is often used as the initial non-invasive diagnostic test in symptomatic patients with suspected obstructive coronary artery disease. Positive standard ECG criteria are quite specific for obstructive coronary artery disease, but there may be a substantial number of false negative tests, including patients with severe coronary artery disease. Also, exercise stress tests frequently yield equivocal results. Instead of detecting the functional consequences, electron-beam computed tomography visualized atherosclerotic plaque disease directly, but its relationship to functional testing has not been clearly delineated. It was the aim of the current study to examine electron-beam computed tomography for the identification of obstructive coronary artery disease in patients with a normal, abnormal, or equivocal exercise stress test. METHODS AND
RESULTS: Symptomatic patients referred for coronary angiography were prospectively included in a consecutive manner if they had no prior diagnosis of coronary artery disease and an unremarkable resting ECG. All patients underwent both exercise stress test and electron-beam computed tomography on the day before coronary angiography. Standard protocols and ECG criteria to diagnose inducible ischaemia were used for the exercise stress test. The electron-beam computed tomography-derived total calcium score was computed according to standard Agatston criteria. Of the 323 patients (mean age, 55+/-11 years; 77% male), 179 (55%) had obstructive coronary artery disease, defined angiographically as luminal diameter narrowing >/=50%. A normal exercise stress test was documented in 105 patients (32.5%), an abnormal exercise stress test ('diagnostic for ischaemia') in 113 (35%), and an equivocal exercise stress test ('inadequate exercise or non-diagnostic ECG-changes') in 105 (32.5%). Multivariate analysis indicated that exercise stress test and electron-beam computed tomography yielded independent information for predicting obstructive coronary artery disease. Sensitivity, specificity and overall accuracy of the exercise stress test were 71%, 75% and 73%, respectively, if equivocal tests were not included, and 50%, 84% and 65% if they were included. Irrespective of the cutpoint regarded as 'positive', the overall accuracy of the electron-beam computed tomography-derived calcium score remained approximately 80% in patients with a normal, abnormal or equivocal exercise stress test. In patients with an equivocal and - to a lesser degree - with a normal exercise stress test, electron-beam computed tomography was able to significantly improve classification regarding obstructive coronary artery disease. Electron-beam computed tomography added no incremental predictive value in patients with an abnormal exercise stress test.
CONCLUSION: In patients who are judged to have an intermediate post-test probability of disease after exercise stress test, electron-beam computed tomography scanning may be a meaningful strategy for further stratification regarding the likelihood of obstructive coronary artery disease. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2000        PMID: 11032694     DOI: 10.1053/euhj.2000.2183

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

Review 1.  Optical coherence tomography and its use in detection of vulnerable plaque.

Authors:  Mehmet Cilingiroglu; Kerem Ozer
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

Review 2.  Vulnerable plaque: definition, detection, treatment, and future implications.

Authors:  Kerem Ozer; Mehmet Cilingiroglu
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

3.  Clinical utility of coronary calcium scoring after nonischemic myocardial perfusion imaging.

Authors:  Randall C Thompson; A Iain McGhie; Kevin W Moser; James H O'Keefe; Tracy L Stevens; John House; Nicolas Fritsch; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

4.  Utility of 64 detector coronary computed tomographic angiography in patients with and without prior equivocal stress tests.

Authors:  Raymond H Chan; Shruti Javali; Mary Lou Ellins; Alison Montgomery; Tej Sheth
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-29       Impact factor: 2.357

5.  Prognostic value of electron-beam computed tomography-derived coronary calcium scores compared with clinical parameters in patients evaluated for coronary artery disease. Prognostic value of EBCT in symptomatic patients.

Authors:  A Schmermund; A Stang; S Möhlenkamp; H Eggebrecht; D Baumgart; V Gilbert; D Grönemeyer; R Seibel; R Erbel
Journal:  Z Kardiol       Date:  2004-09

6.  Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus.

Authors:  Thomas H Schindler; Jerson Cadenas; Alvaro D Facta; Yanjie Li; Manfred Olschewski; James Sayre; Jonathan Goldin; Heinrich R Schelbert
Journal:  Eur Heart J       Date:  2009-12       Impact factor: 29.983

7.  Measurement of coronary calcium scores by electron beam computed tomography or exercise testing as initial diagnostic tool in low-risk patients with suspected coronary artery disease.

Authors:  Christiane A Geluk; Riksta Dikkers; Patrick J Perik; René A Tio; Marco J W Götte; Hans L Hillege; Rozemarijn Vliegenthart; Janneke B Houwers; Tineke P Willems; Matthijs Oudkerk; Felix Zijlstra
Journal:  Eur Radiol       Date:  2007-09-28       Impact factor: 5.315

8.  Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification.

Authors:  Dongxing Zhu; Patrick W F Hadoke; Junxi Wu; Alex T Vesey; Daniel A Lerman; Marc R Dweck; David E Newby; Lee B Smith; Vicky E MacRae
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.